{
  "id": 3945890,
  "title": "Daiichi Sankyo to give commercial team a makeover; Novo Nordisk's GPCR partner finds CMO",
  "url": "https://urgent.news/2026/08/28/daiichi-sankyo-to-give-commercial-team-a-makeover-novo-nordisks-gpcr",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-28T11:00:21.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/daiichi-sankyos-commercial-team-to-get-a-makeover-novo-nordisks-gpcr-partner-finds-cmo/"
  },
  "original_language": "en",
  "account": null,
  "summary": "→ Daiichi Sankyo will retool its commercial organization, and Ken Keller will be at the center of it all as chief commercialization officer. On April 1, 2027, the Japanese pharma will split the commercialization efforts ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}